Breaking News

Cambrex Completes Iowa Site Expansion

Expands capacity and capabilities for small molecule APIs and large scale assets

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cambrex Corp. has completed and validated a $50 million production and warehousing expansion at its cGMP Charles City, Iowa site. The investment expands capacity and capabilities for small molecule APIs and large scale assets.   The 7,500 sq. ft. multi-purpose manufacturing facility will initially add 70m3 of glass lined and Hastelloy reactors from 7m3 to 16m3, along with 6m2 Hastelloy agitated filter dryers for multi-purpose configuration, and will be capable of handling potent APIs at an Occ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters